TP53 and lymphoma: In Eμ‐Myc transgenic animals, lymphoma development requires the acquisition of additional genetic alterations, which commonly comprise of disruption of the p19ARF‐Mdm2‐p53 pathway or overexpression of Bcl2 34, 35.